| Date | Time | Source | Headline | Symbol | Company |
| 03/04/2010 | 2:57PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 03/04/2010 | 8:53AM | Business Wire | Impax Laboratories to Present at the Cowen & Co. 30th Annual Health Care Conference on March 9, 2010 | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 03/02/2010 | 8:45AM | Business Wire | Impax Laboratories Receives Final FDA Approval for Generic FLOMAX® 0.4mg Capsules and Immediately Commences Shipment | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 02/26/2010 | 1:00PM | Business Wire | Impax Laboratories to Appear at the RBC Capital Markets Healthcare Conference on Tuesday, March 2, 2010 | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 02/25/2010 | 7:30AM | Business Wire | Impax Laboratories Reports Record Growth in Revenue, Net Income and Earnings for the Fourth Quarter and Full Year 2009 | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 02/19/2010 | 9:05AM | Dow Jones News | UPDATE: Shire Plans To Undercut Cerezyme As Profit Rises | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 01/29/2010 | 4:04PM | Edgar (US Regulatory) | Statement of Ownership (SC 13G) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 01/22/2010 | 5:01PM | Dow Jones News | Biovail Has Issues With Teva's Wellbutrin XL Study | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 01/21/2010 | 10:00AM | Business Wire | Impax Laboratories Schedules Conference Call for Fourth Quarter and Full Year 2009 Financial Results | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 01/15/2010 | 9:00AM | Business Wire | Impax Laboratories Confirms Patent Challenge Relating to WELCHOL® 625 mg Tablets | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 01/14/2010 | 3:39PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 01/12/2010 | 10:44AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 01/06/2010 | 10:00AM | Business Wire | Impax Laboratories to Present at the 28th Annual J.P. Morgan Healthcare Conference | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 12/30/2009 | 3:07PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 12/02/2009 | 10:30AM | Business Wire | Impax Laboratories Acquires Rights to Abbreviated New Drug Applications | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 11/24/2009 | 9:30AM | Business Wire | Global Pharmaceuticals Awards Grant to Myasthenia Gravis Alliance | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 11/20/2009 | 9:00AM | PR Newswire (US) | Impax Laboratories Drives Stronger Performance with IBM Business Analytics | NASDAQ:IPXL | |
| 11/12/2009 | 7:07PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 11/12/2009 | 4:58PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 11/10/2009 | 4:14PM | Business Wire | Impax Laboratories to Present at the Credit Suisse 18th Annual Healthcare Conference | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 11/04/2009 | 3:08PM | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 11/03/2009 | 10:36AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 11/03/2009 | 7:30AM | Business Wire | Impax Laboratories Continues Trend of Solid Growth in Revenue, Profit and Earnings for the Third Quarter 2009 | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 10/30/2009 | 10:45AM | Business Wire | Impax Laboratories Confirms Patent Challenge Relating to TRICOR® 48mg and 145mg Tablets | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 10/26/2009 | 9:09AM | Business Wire | Impax Pharmaceuticals Initiates Second Phase III Trial of IPX066 in Parkinson’s Disease | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 10/13/2009 | 4:35PM | Business Wire | Impax Laboratories to Host Third Quarter 2009 Earnings Conference Call and Webcast on November 3 | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 10/13/2009 | 2:17PM | Dow Jones News | Shire, Sandoz Settle Attention Deficit Treatment Litigation | NASDAQ:IPXL | Impax Laboratories Inc. |
| 10/07/2009 | 9:51AM | Dow Jones News | Impax To Begin Selling Generic Flomax In March | NASDAQ:IPXL | Impax Laboratories Inc. |
| 10/07/2009 | 7:00AM | Business Wire | Impax Laboratories Settles Pending Litigation for FLOMAX® | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 10/05/2009 | 8:00AM | Business Wire | Impax Laboratories Receives Tentative FDA Approval for Generic FLOMAX® 0.4mg Capsules | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |